| MolName | (5Z)-3-[(2-chlorophenyl)methyl]-5-[[2-[(2-hydroxy-2-phenylethyl)amino]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one |
| MolecularFormula | C27H21N4O3ClS2 |
| Smiles | OC(CNC(N=C1N2C=CC=C1)=C(/C=C(/C(N1Cc(cccc3)c3Cl)=O)\SC1=S)C2=O)c1ccccc1 |
| InChI | InChI=1S/C27H21ClN4O3S2/c28-20-11-5-4-10-18(20)16-32-26(35)22(37-27(32)36)14-19-24(29-15-21(33)17-8-2-1-3-9-17)30-23-12-6-7-13-31(23)25(19)34/h1-14,21,29,33H,15-16H2/t21-/m0/s1 |
| InChIK | FFRWXEDQRDWBJQ-NRFANRHFSA-N |
| TotalMolweight | 549.074 |
| Molweight | 549.074 |
| MonoisotopicMass | 548.074358 |
| CLogP | 2.067 |
| CLogS | -6.398 |
| H Acceptors | 7 |
| H Donors | 2 |
| TotalSurfaceArea | 395.67 |
| Relative PSA | 0.28999 |
| PolarSurfaceArea | 142.63 |
| Druglikeness | 6.8055 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.48649 |
| Fragments | 1 |
| Non HAtoms | 37 |
| NonCHAtoms | 10 |
| Electronegative Atoms | 10 |
| StereoCenters | 1 |
| Rotatable Bond | 7 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 12 |
| Sp3Atoms | 6 |
| Symmetricatoms | 2 |
| Amides | 2 |
| BasicNitrogens | 1 |
| StereoCon | racemate |
Click to Load Molecule:
1 - (5Z)-3-[(2-chlorophenyl)methyl]-5-[[2-[(2-hydroxy-2-phenylethyl)amino]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one | 2 - (5Z)-3-[(2-chlorophenyl)methyl]-5-[[2-[(2-hydroxy-2-phenylethyl)amino]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one